Lataa...
599. LiaF is an Activator of the LiaR-Mediated Response Against Daptomycin and Antimicrobial Peptides in Multidrug-Resistant Enterococcus faecalis (Efs)
BACKGROUND: Daptomycin (DAP) is a key first-line agent for the treatment of vancomycin-resistant enterococcal infections. Resistance to DAP in enterococci is regulated by the liaFSR three-component regulatory system that consists of a histidine kinase sensor (LiaS), a response regulator (LiaR) and a...
Tallennettuna:
| Julkaisussa: | Open Forum Infect Dis |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6810921/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.668 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|